
NIBEC Gains Recognition at BIO USA for Peptide Technology
NIBEC, a specialized peptide fusion biotechnology company, is set to accelerate global co-development and commercialization of its sarcopenia treatment and next-generation drug delivery platform PEPTARDEL. On June 4, NIBEC announced that it had engaged in …